BCYC

BICYCLE THERAPEUTICS PLC

BCYC·088786108·US·ADR·Healthcare - Biotechnology-13D/G

BCYC (BICYCLE THERAPEUTICS PLC) is held by 54 institutional investors as of Q1 2026. Largest holders: BAKER BROS. ADVISORS LP ($50.5M), PRINCIPAL FINANCIAL GROUP INC ($5.5M), PRICE T ROWE ASSOCIATES INC /MD/ ($4.8M). Net institutional sentiment: Mixed.

54
Holders
(4 Elite)
$89.2M
Total Value
55% (55)
Consensus
30 buying - 25 selling
13F: Insider & Congress:
BCYCSmart Money Verdict
View all
Held by 54 funds
4 elite
Who's Trading
InsiderLKLee KevinSell $7KJul 6, 2026
InsiderSMSkynner MichaelSell $2KJul 6, 2026
InsiderHFHannay Michael Charles FergusonSell $1KJul 6, 2026
InsiderPSPerry Jennifer ScottSell $185.33Jul 6, 2026
InsiderPSPerry Jennifer ScottSell $1KJul 6, 2026
InsiderTAThompson Travis AlvinSell $448.24Jul 6, 2026
InsiderLKLee KevinSell $25KJul 2, 2026
InsiderSMSkynner MichaelSell $8KJul 2, 2026
ActivistLFLONG FOCUS CAPITAL MANAGEMENT, LLC6.6%May 15, 2026
ActivistARArmistice Capital, LLC6.8%May 15, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
10.9M$50.5M0.3%-78.84%
0
Increased
1.2M(+2.3%)$5.5M0.0%-66.59%
28
Decreased
1M(-12.3%)$4.8M0.0%-80.75%
0
Increased
979,300(+72.8%)$4.5M0.0%-58.01%
40
Increased
618,327(+32.9%)$2.9M0.0%-71.13%
34
Increased
615,833(+5.3%)$2.7M0.0%-34.52%
28
Decreased
428,684(-10.1%)$2M0.0%-64.66%
0
Increased
377,335(+872.6%)$1.8M0.0%-21.72%
42
Increased
377,085(+39.0%)$1.7M0.0%-58.12%
34
New
308,617$1.4M0.0%-19.82%
35
Decreased
283,986(-13.1%)$1.3M0.0%-47.59%
0
Decreased
278,992(-16.2%)$1.3M0.0%-65.18%
0
Unchanged
275,000$1.3M0.0%-40.26%
0
Increased
218,115(+245.2%)$1M0.0%-27.56%
40
Increased
164,800(+24.8%)$764,6720.0%-37.89%
30
Increased
130,422(+69.9%)$605,1580.0%-62.06%
36
Unchanged
127,863$593,2840.0%-79.03%
0
Increased
115,000(+46.7%)$533,6000.0%-30.95%
33
Increased
110,147(+345.4%)$511,0820.0%-23.86%
39
Increased
106,392(+123.2%)$493,6590.0%-28.54%
39

Showing 1-20 of 68

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used